UK markets open in 1 hour 28 minutes

Cara Therapeutics, Inc. (CARA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
12.15+0.18 (+1.50%)
At close: 4:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
128,924
135,082
19,886
13,469
911
Operating expenses
Research development
93,446
107,851
113,820
75,531
48,524
Selling general and administrative
23,546
21,749
17,657
15,238
11,795
Total operating expenses
117,099
129,697
131,565
90,851
60,396
Operating income or loss
11,825
5,385
-111,679
-77,382
-59,485
Total other income/expenses net
1,637
2,334
4,490
2,980
1,156
Income before tax
13,462
7,719
-107,189
-74,402
-58,329
Income tax expense
-569
-691
-816
-389
-204
Income from continuing operations
14,031
8,410
-106,373
-74,013
-58,125
Net income
14,031
8,410
-106,373
-74,013
-58,125
Net income available to common shareholders
14,031
8,410
-106,373
-74,013
-58,125
Basic EPS
-
0.18
-2.49
-2.06
-1.86
Diluted EPS
-
0.18
-2.49
-2.06
-1.86
Basic average shares
-
47,413
42,669
35,893
31,203
Diluted average shares
-
47,915
42,669
35,893
31,203
EBITDA
-
5,594
-111,481
-77,012
-58,990